Clinical trial
Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices
NCT00039767 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00039767 |
|---|---|
| Title | Heparin Versus Lepirudin Flushes in Preventing Blockage of Venous Access Devices |
| Official title | Heparin vs. Lepirudin Flushes in Preventing Withdrawal Occlusion of Tunneled, Open-Ended Venous Access Devices: A Blinded, Randomized, Clinical Trial |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Thrombosis |
| Intervention type | Drug |
| Interventions | Lepirudin |
| Enrollment | 340 |
| Start date | May 1, 2002 |
| Completion | Apr 1, 2006 |
| First posted | Jun 10, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: